Pantera Minerals Limited PFE
ASX · Australia · Non-Energy Minerals
AUD 0.01500.00 (0.00%)
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
New and acquired products brought in $3.2 billion globally in the second quarter, as Pfizer steers resources toward growth areas.
AbbVie offers faster-growing drug sales and a rising payout, while Pfizer’s much higher yield comes with a tougher recovery to prove.
Pfizer’s 6% yield remains funded, yet weaker cash generation and heavy debt leave income investors with little room for error.
Citi says AstraZeneca’s breast cancer setback is manageable as a narrower Etcamah launch and wider pipeline support its valuation.